Mylan NV (MYL)

36.51
NASDAQ : Health Care
Prev Close 36.06
Day Low/High 36.07 / 37.15
52 Wk Low/High 33.60 / 55.51
Avg Volume 6.82M
Exchange NASDAQ
Shares Outstanding 535.11M
Market Cap 19.30B
EPS 1.80
P/E Ratio 72.12
Div & Yield N.A. (N.A)

Latest News

Closing Bell: Credit Suisse to Cut Jobs; Dow and S&P 500 Hit All-Time High

Closing Bell: Credit Suisse to Cut Jobs; Dow and S&P 500 Hit All-Time High

The Dow's winning streak continued with the index closing higher for the 18th time in 22 sessions and clinching a record settlement for the third day in a row.

Dow, S&P 500 Trade at Session Highs in Broad Wall Street Rally

Dow, S&P 500 Trade at Session Highs in Broad Wall Street Rally

The S&P 500 and Dow Jones Industrial Average trade at session highs early Wednesday afternoon as a broad rally overshadows a slump in health care stocks.

S&P 500 and Dow Reverse Losses to Post Intraday Records

S&P 500 and Dow Reverse Losses to Post Intraday Records

The S&P 500 reverses an earlier loss to post small gains, trading at a new intraday record, thanks to broad gains across all sectors save for health care.

Mylan: This Is Going to Take a While

Mylan: This Is Going to Take a While

The stock remains pointed down with few signs of encouragement for bulls.

Mylan Aims to Trim Global Workforce

Mylan Aims to Trim Global Workforce

The EpiPen-maker is looking to cut less than 10% of its workforce, a spokeswoman confirmed Tuesday.

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Mylan NV Investors

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Mylan NV Investors

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Mylan N.

Some 'January Effect' Stock Picks

Some 'January Effect' Stock Picks

Small-caps could also benefit from abating tax-loss selling.

Mylan Will Not Testify Before Senate Judiciary Committee

Mylan Will Not Testify Before Senate Judiciary Committee

The drug company declined Sen. Chuck Grassley's request to testify on pricing practices later this month.

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Mylan N.V. To Contact The Firm

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Mylan N.V. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

Andrew Left: Dump Mallinckrodt

Andrew Left: Dump Mallinckrodt

Famed short-seller says drugmaker at risk of a government crackdown.

Dow, Lifted by Financials, Finishes at Record High; Nasdaq Slips

Dow, Lifted by Financials, Finishes at Record High; Nasdaq Slips

Wall Street runs at two speeds as a rally in financials sent the Dow Jones Industrial Average to close at records, while a selloff in tech sank the Nasdaq.

Dow Hits New Records, Nasdaq Falls as Tech Stocks Decline

Dow Hits New Records, Nasdaq Falls as Tech Stocks Decline

Wall Street remains divided on Thursday as investors try to gauge the types of policies president-elect Donald Trump could enact.

Midday Report: Pharma Stocks Jump on Trump Win; Nasdaq Plummets

Midday Report: Pharma Stocks Jump on Trump Win; Nasdaq Plummets

Wall Street ran at two speeds with the Dow Jones Industrial Average setting a record high earlier in the day while the Nasdaq plummeted into the red.

S&P 500, Nasdaq Turn Red in Erratic Post-Election Trading

S&P 500, Nasdaq Turn Red in Erratic Post-Election Trading

Wall Street runs at two speeds on Thursday with the Dow Jones Industrial Average setting a record high and the S&P 500 and Nasdaq slipping.

Stock Futures Rise as Wall Street Rally Continues After Trump's Win

Stock Futures Rise as Wall Street Rally Continues After Trump's Win

Stock futures move higher on Thursday with the Dow Jones Industrial Average set to open at a high.

In Case You Missed It Nov. 9: Goldman, GoPro, GTT and the GOP

In Case You Missed It Nov. 9: Goldman, GoPro, GTT and the GOP

Impax is Slowly Stealing Market Share from Mylan; Goldman Names New Partners; Twinkie Maker Hostess Brands Preps for Its Next Chapter; and more from The Street.

Mylan Reports Worse-Than-Expected Earnings Thanks to EpiPen

Mylan Reports Worse-Than-Expected Earnings Thanks to EpiPen

The pharmaceutical company reported earnings per share of $1.38, missing estimates by 7 cents per share.

Stocks Surge After Trump Victory

Stocks Surge After Trump Victory

Stocks close at session highs on Wednesday as the idea of a Trump presidency settles in. Financial and health care sectors lead the market.

Stocks Maintain Solid Gains After Donald Trump Wins the White House

Stocks Maintain Solid Gains After Donald Trump Wins the White House

Stocks post solid gains Wednesday after plunging overnight following Donald Trump's surprising victory in the U.S. presidential race.

Donald Trump Election Victory Boosts Some Stocks and Sectors

Donald Trump Election Victory Boosts Some Stocks and Sectors

As we all know, the stock market and the economy abhor uncertainty.

Stocks Turn Positive After Trump's Surprising Election Win

Stocks Turn Positive After Trump's Surprising Election Win

Stocks turn positive Wednesday as investors gauge a Donald Trump presidency on markets. Drug, biotech and financial stocks jump.

Stock Futures Remain Sharply Lower Following Trump's Victory

Stock Futures Remain Sharply Lower Following Trump's Victory

Stock futures fall on Wednesday as voters elect Donald Trump as the next U.S. president.

Generics Fuel Solid 3Q for Taro Pharmaceutical

Generics Fuel Solid 3Q for Taro Pharmaceutical

Days after price fixing allegations go public over generic drugs, Taro posts financials showing net sales up thanks to, yes that's right, its U.S. generic drug business.